Brisbane, CA, United States of America
Myokardia, Inc.
Patents = 11
Trademarks = 18
Forward Citations = 49
where 'Filed Patents' based on already Granted Patents
where 'Inventors Filed' based on already Granted Patents
43 inventors (with patents filed for the assignee):
Myokardia is a biopharmaceutical company focused on discovering, developing and commercializing targeted therapies for the treatment of serious cardiovascular diseases. The company's lead candidate, mavacamten, is being developed for the treatment of hypertrophic cardiomyopathy, a genetic heart condition. Myokardia is dedicated to improving the lives of patients with cardiovascular diseases through innovative therapies.
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com